Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir-Reference-Cited by-同舟云学术

Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir

Published:2021-12-05 Issue: Volume: Page:
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Campbell Lucy¹²,Ibrahim Fowzia¹,Barbini Birgit²,Samarawickrama Amanda³,Orkin Chloe⁴,Fox Julie¹⁵,Waters Laura⁶^ORCID,Gilleece Yvonne⁷⁸^ORCID,Tariq Shema⁹^ORCID,Post Frank A.¹²^ORCID,Post Frank,Adegbaju Oluwayomi,Hamzah Lisa,Bhagwandin Priya,Canoso Ana,Kegg Stephen,Moussaoui Tarik,Lwanga Julianne,Sharp Alice,Aminata Mohammed,John‐Baptiste Ange,Hamzah Lisa,Prime Katia,Okolo Olanike,Waters Anele,Cartier Andrea,Johnson Margaret,Nightingale Alice,Edwards Jonathan,Fernandez Thomas,Hemat Nargis,Ainsworth Jonathan,Vincent Rachel,Barbour Lisa,Kirk Sarah,Adams Tanya,Knott Alyson,

Affiliation:

1. King’s College London London UK

2. King’s College Hospital NHS Foundation Trust London UK

3. Sexual Health South West London London UK

4. Queen Mary University of London and Barts Health NHS Trust London UK

5. Guy’s and St Thomas’ Hospitals NHS Foundation Trust London UK

6. Mortimer Market Centre London UK

7. University Hospitals Sussex NHS Trust Brighton UK

8. Brighton & Sussex Medical School Brighton UK

9. University College London London UK

Funder

ViiV Healthcare